Clinical Trials Search Results

Results 21-30 of 41 for your search
Show Search Criteria
Cabozantinib S-malate and Nivolumab with or without Ipilimumab in Treating Patients with Metastatic Genitourinary Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 8 locations
Modified Immune Cells (LN-145) and Pembrolizumab in Treating Patients with Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: Roswell Park Cancer Institute, Buffalo, New York
Atezolizumab, Carboplatin, and Gemcitabine Hydrochloride in Treating Patients with Metastatic or Unresectable and Locally Advanced Urothelial Carcinoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: Indiana University / Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
Abexinostat and Pembrolizumab in Treating Patients with MSI-High Locally Advanced or Metastatic Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: UCSF Medical Center-Mount Zion, San Francisco, California
Pembrolizumab with Combination Chemotherapy in Treating Participants with Locally Advanced or Metastatic Small Cell / Neuroendocrine Cancers of Urothelium or Prostate
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Avelumab and Docetaxel in Treating Patients with Platinum Refractory or Ineligible Metastatic Urothelial Cancer
Status: Active
Age: 18 to 85 years
Gender: Male or Female
Location: University of Iowa / Holden Comprehensive Cancer Center, Iowa City, Iowa
Cabozantinib and Pembrolizumab as First Line Therapy in Treating Patients with Cisplatin-Ineligible Metastatic, Locally Advanced, or Unresectable Urothelial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: Huntsman Cancer Institute / University of Utah, Salt Lake City, Utah
Atezolizumab and PGV001 in Treating Patients with Locally Advanced or Metastatic Urothelial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: Icahn School of Medicine at Mount Sinai, New York, New York